Poulsen, Raewyn C.
Jain, Lekha
Dalbeth, Nicola
Funding for this research was provided by:
Health Research Council of New Zealand (20/199)
Auckland Medical Research Foundation (1117012)
Article History
Received: 25 November 2022
Accepted: 29 March 2023
First Online: 12 April 2023
Declarations
:
: Not applicable.
: Not applicable.
: Nicola Dalbeth has received consulting fees from AstraZeneca, Dyve Biosciences, Horizon, Selecta, Arthrosi, JW Pharmaceutical Corporation, PK Med, LG Chem, JPI, PTC Therapeutics, Protalix, outside the submitted work. (Work related to gout rather than osteoarthritis). All other authors have no competing interests.